Disc Medicine, Inc.

NASDAQ:IRON

Biotechnology

Healthcare
$76.11 -0.03%

-$0.02 today

Market cap
$2.92B
Beta
2.10
P/E (TTM)
-11.2
EPS (TTM)
-$6.28
52W Low $40.00High $99.50

Volume 0.65M

Average 0.47M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$180.39M

FY 2025 · Annual

Investing Cash Flow

-$394.30M

FY 2025 · Annual

Financing Cash Flow

$473.41M

FY 2025 · Annual

+116.8% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(35.97M)(46.83M)(76.43M)(109.36M)(212.18M)
Depreciation & Amortization32K89K100K156K281K
Deferred Income Tax00000
Stock-Based Compensation507K2.09M5.53M16.82M34.34M
Change in Working Capital1.29M2.13M(2.95M)3.23M3.53M
Accounts Receivables00000
Inventory00000
Accounts Payables1.32M526K(3.74M)(4.68M)1.07M
Other Working Capital(29K)1.6M788K7.91M2.46M
Other Non-Cash Items6.61M272K290K(4.77M)(6.36M)
Operating Cash Flow(27.53M)(42.25M)(73.46M)(93.93M)(180.39M)
Capital Expenditures(68K)(151K)(89K)(505K)(933K)
Acquisitions (Net)00000
Purchases of Investments000(386.63M)(849.59M)
Sales of Investments00094.8M456.22M
Other Investing Activities00000
Investing Cash Flow(68K)(151K)(89K)(292.33M)(394.3M)
Debt Repayment(4.58M)0028.99M0
Common Stock Issued68K53.5M199.08M187.3M472.83M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities4.58M95.48M40.3M2.02M578K
Financing Cash Flow89.93M148.98M239.38M218.31M473.41M
Effect of Forex Changes00000
Net Change in Cash62.33M106.58M165.83M(167.94M)(101.29M)
Free Cash Flow(27.6M)(42.4M)(73.55M)(94.43M)(181.33M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$212.2M
+ D&A$281.0K
+ Stock-Based Comp$34.3M
+ Deferred Tax$0
+ Working Capital$3.5M
- Other Non-Cash-$6.4M
= Operating Cash Flow-$180.4M
- Capex-$933.0K
= Free Cash Flow-$181.3M

Analysis

FY2025 free cash flow is -$181.3M. FCF conversion is 85.5% of net income. Operating cash flow was -$180.4M, with capex of -$933.0K. The largest bridge item is Stock-Based Comp at $34.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
424B5424B5 filingNov 5, 2026
SC 13D/ASC 13D/A filingOct 26, 2026

Does IRON generate free cash flow?

Disc Medicine, Inc. (IRON) generated -$181.33M of free cash flow in fiscal 2025.

How much operating cash flow does IRON produce?

Operating cash flow was -$180.39M, before capital expenditures of $933,000.00.